Medtech grants in France

Open

Funds research consortia developing biotechnology-based interventions, biomarkers or non-animal test methods that target the root causes of age-related disease.

Open

Funds European consortia developing breakthrough solutions across AI, climate, energy, materials, medical, and quantum fields.

Open

Funds €4M projects that build and field-test search-and-rescue tech — drones, robotics, sensors — for wildfires, earthquakes and other hazardous disasters.

Open

Funds European doctoral networks enabling multi-country training in life and engineering sciences.

Open

Supports small and medium firms in early-stage deep technologies through public proposals and commercialization mentoring.

Open

Funds frontier research by established researchers in Europe-backed programmes across any discipline with high-risk, high-impact ambitions.

Open

Funds investigator-led frontier research across disciplines, enabling high-risk discovery with strong scientific autonomy.

Open

Funds healthcare programs building resilience and prevention in cancer, rare diseases, and cardiovascular health.

Open

Offers open access collaboration through Eureka Network Projects so small enterprises can join international innovation groups.

Open

Funds small and medium enterprises across Europe via Eurostars Call 11 for collaborative innovation with international partners.

Open

Supports internationally mobile postdoctoral researchers placed in Israeli institutions to build independent research careers through EU mobility fellowships.

Open

Offers The Audacious Project invitation-only multi-issue funding for social-impact ideas with broad partner backing.

Scheduled

Funds two €1.5M projects that adapt European AI to local data, innovation hubs and real-world challenges in low- and middle-income countries.

Scheduled

Funds two €5.5M projects that let communities map the health risks of polluted soils and shape safer local responses.

Scheduled

Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.

Scheduled

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

Scheduled

Funds the next phase of Europe’s pandemic-preparedness partnership, clinical networks and One Health research ecosystem.

Scheduled

Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.

Scheduled

Funds €6–8M projects that make cell-free protein synthesis practical for discovering and producing peptide- and protein-based biologicals.

Scheduled

Funds four €4–5M PCP projects that help healthcare systems and communities adapt to climate-related health risks.

Scheduled

Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one Flavivirus.

Scheduled

Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.

Scheduled

Funds antibacterial and antifungal therapies that expand treatment options against antimicrobial-resistant infections.

Scheduled

Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.